pipette
ENEnglish

Recurrent astrocyte transcriptional states with spatial and functional specialization are induced by brain metastases independently of their primary tumor origin

C. Hernandez-Oliver, L. Cordon-Barris, A. Sartorius-Yanez, M. Gonzalez-Bermejo, D. Maspero, M. Elosua-Bayes, N. Priego, L. Cuarental, L. Alvaro-Espinosa, O. Sanchez, V. Fernandez, G. Palou-Marquez, C. Parra-Perez, A. Stammberger, A. Rosado, A. Dopazo, M. A. Moro, M. Schmitz, H. Heyn, RENACER, F. Al-Shahrour, M. Valiente

Preprint

En palabras de los autores

Reactive astrocytes have emerged as important components of the brain metastasis niche, yet a state-resolved framework for metastasis-associated astrocyte biology is still lacking. Here, we integrate single-cell and spatial transcriptomics across syngeneic breast, lung and melanoma models of brain metastases to define a state-resolved astrocyte landscape. We identify recurrent tumor-associated astrocyte states shared across tumor origins, map their spatial distribution, and find that a subset, which we term AST-BrM, becomes selectively reprogrammed at the tumor-microenvironment interface, supporting niche-coupled organization rather than a diffuse brain-wide reactive response. AST-BrM defines distinct metastasis-associated astrocyte states at the peritumoral interface, distinguishes them from homeostatic-like astrocytes beyond generic inflammatory activation, and resolves into two therapeutically actionable programs: an AP-1-high axis and a STAT3+/HOPX+-associated axis. Genetic and pharmacologicall perturbations establish functional relevance, and an AP-1/c-FOS-driven signature is associated with clinical outcome. Together, these findings define conserved, spatially organized and actionable astrocyte programs that drive brain metastasis progression.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 18 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.16.766881